BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2011
View Archived Issues
Alnylam files CTA in U.K. for RNAi therapeutic ALN-PCS in severe hypercholesterolemia
Read More
Axelar completes phase I/II safety study of AXL-1717 in solid tumors
Read More
Transcend-trastuzumab conjugate BT-2111 shows promise as therapeutic for metastatic breast cancer
Read More
Adalimumab is beneficial in hidradenitis suppurativa in phase II study
Read More
High palladin levels in tumor-associated stromata predict poor survival in renal cell carcinoma
Read More
Briakinumab is superior to etanercept in treating chronic plaque psoriasis
Read More
SCYX-7158 shows promise in model of stage 2 human African trypanosomiasis
Read More
Merck & Co. discloses new tyrosine-protein kinase SYK inhibitors
Read More
Universitat de Barcelona and CSIC present new glucosylceramidase inhibitors
Read More
Sunovion claims new metabotropic glutamate mGlu5 receptor receptor ligands
Read More
Astellas to transfer rights for minor tranquilizer Balance to Maruishi Pharmaceutical
Read More
Biogen Idec and Unilabs collaborate on companion diagnostic test for Tysabri-treated patients
Read More
Novel dipeptidyl peptidase 1 inhibitors reported by Janssen Pharmaceutica
Read More
Titan Pharmaceuticals reports topline results from phase III Probuphine trial
Read More
New glucokinase activators patented by Astellas Pharma
Read More
ATX-101 is safe and reduces submental fat in phase II trial
Read More
Phase II oral interferon study for prevention of hepatitis C relapse progresses
Read More
Sunshine Biopharma's Adva-27a effectively kills multidrug-resistant breast cancer cells in vitro
Read More
Enrollment complete in first cohort of Advaxis' phase II ADXS-HPV study
Read More
Gamida Cell-Teva joint venture clear to continue accrual in phase III StemEx trial
Read More
Micromet and Amgen form BiTE antibody collaboration
Read More
DMC completes data review from 535 participants of phase III trial HEAT
Read More
Zuplenz available for licensing to new commercialization partners
Read More
Arena Pharmaceuticals reports phase I findings on APD-811 in PAH
Read More
Zogenix and Durect enter development agreement for needle-free formulation of risperidone
Read More